AMD-QoL
The AMD Quality of Life (AMD-QoL) scale is a disease-specific instrument designed to measure the impact of age-related macular degeneration on patient-reported health-related quality of life. Developed by Mitchell, Bradley, and colleagues (2005), the AMD-QoL addresses concerns unique to macular disease: central vision loss, reading difficulty, facial recognition, driving impairment, and emotional burden. It serves as a primary or secondary outcome in AMD clinical trials and informs patient-centered care decisions.
Kilderegistrering
Citater kopieret ordret fra metodens kilderegistrering. Ingen påstandsniveauverifikation er udledt heraf.
- Mitchell, J., Bradley, C., Anderson, S. J., et al. (2005). Perceived impact of retinal impairment on quality of life: the AMD and Cataract Symptom Effect Questionnaire. Health Qual Life Outcomes, 3(1), 12. · DOI 10.1186/1477-7525-3-25
- Submacular Surgery Trials (SST) Research Group. (2004). Quality of life in patients with subfoveal choroidal neovascularization due to age-related macular degeneration. Arch Ophthalmol, 122(11), 1635-1645. · URL
Kuraterede påstande
Påstande gemt i bevis-loggen, hver med sin egen vurdering.
Denne visning opfinder ikke en påstandsvurdering, når loggen ingen har.
Relaterede metoder
Genereret fra metodegrafen og vist som maskinelt foreslåede relationer — ingen bevispåstand er udledt.